Crystalline forms of a farnesyl dibenzodiazepinone

Details for Australian Patent Application No. 2007209992 (hide)

Owner Thallion Pharmaceuticals Inc.

Inventors Yeboah, Faustinus; Roux, Emmanuelle; Harvey, Michael; Ranger, Maxime; Morris, Patrick; McAlpine, James

Agent Shelston IP

Pub. Number AU-A-2007209992

PCT Pub. Number WO2007/089657

Priority 60/763,377 31.01.06 US

Filing date 26 January 2007

Wipo publication date 9 August 2007

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

C07D 243/10 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/089657 Priority application(s): WO2007/089657

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007210000-Storage-stable cellular whole blood composition containing elevated amounts of D-dimer

2007209981-Potassium channel inhibitors